Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Risk Assessment Equipment Supplied In Usa
32 equipment items found
Manufactured by:Randox Laboratories Ltd. based inCrumlin, UNITED KINGDOM
Lipid tests are used to assess an individual’s risk of heart attack or stroke. Lipid tests are the most important of the cardiac risk tests as they provide a clear indication of whether someone is likely to have a coronary event caused by a blockage of the blood vessels or atherosclerosis (narrowing of the arteries caused by build-up of ...
Manufactured by:Babyscripts based inWashington, DISTRICT OF COLUMBIA (USA)
With Population Health, this data flows back to insurance payers, who then can access their members through the point of care. Utilizing the ability to assess for and dynamically address medical and social risks throughout the pregnancy and parenting journey, this functionality addresses some of the structural issues of care coordination and access to care while ...
Manufactured by:Randox Laboratories Ltd. based inCrumlin, UNITED KINGDOM
Randox is a leading provider of diagnostic reagents for the assessment of cardiovascular disease risk. Our extensive menu of cardiac biomarkers within the cardiology reagents panel include: routine lipid tests such as Homocysteine, hsCRP, Apo A-I, Apo A-II, Apo B and Lp(a), as well as, unique assays for cardiac risk ...
by:Accruent based inAustin, TEXAS (USA)
Manage attributes of all network connected medical devices. Conduct risk assessments, reconcile MDS2 data and other security attributes against inventory, and remediate potential risks and vulnerabilities. Automate workflows unique to your ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Metastasis: DecisionDx-SCC is now commercially available. DecisionDx-SCC is clinically validated as a significant predictor of metastasis and the strongest predictor of risk compared to traditional clinical and pathological factors. DecisionDx-SCC complements traditional prognostic risk assessment ...
Manufactured by:Savaria Patient Care based inSt. Louis, MISSOURI (USA)
This sling incorporates COOLMAX freshFX EcoMade fiber which offers moisture management and superior breathability, making it suitable for prolonged use upon risk assessment. Furthermore, its antimicrobial silver ion technology mitigates bacterial growth and odors, promoting a safe and hygienic environment. Constructed from 100% polyester Silva-Spacer fabric, it's ...
Manufactured by:Tempus based inChicago, ILLINOIS (USA)
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer types, including common hereditary cancers (breast, ovarian, colorectal, endometrial, prostate, pancreatic) and others (renal/urinary tract, gastric, melanoma, thyroid, endocrine, ...
Manufactured by:Air Techniques, Inc based inMelville, NEW YORK (USA)
Spectra is a non-invasive caries detection aid that helps eliminate the guesswork in detecting and diagnosing tooth decay and enhances case acceptance through better patient education. CamX Spectra Caries Detection Aid is the only caries detection aid that uses fluorescence technology to visualize and discover caries earlier, as well as plaque and ...
Manufactured by:BeamMed Inc. based inPlantation, FLORIDA (USA)
Sunlight MiniOmni and Omnisense™ are currently the only bone sonometers on the market that can measure at multiple skeletal sites. Multi-site testing provides a better chance of identifying individual cases of osteoporosis as well as enabling flexibility in testing patients who cannot be tested at a particular skeletal site. Multi-site measurement also has advantages in monitoring treatment ...
by:Diabetomics, Inc. based inHillsboro, OREGON (USA)
The Lumella® Test, The New Point-of-Care Blood Test Helps in Early Detection of Preeclampsia; The Lumella® test estimates the concentration of Glycosylated Fibronectin, a new pregnancy specific biomarker to accurately assess the risk of preeclampsia. The Lumella® test requires a simple finger stick and can be performed in physician’s ...
Manufactured by:Babyscripts based inWashington, DISTRICT OF COLUMBIA (USA)
Pregnancy app with patient and provider-facing portals; daily education, reminders, and checklists to support moms through prenatal and postpartum ...
Manufactured by:MEDI+SIGN based inSmithsburg, MARYLAND (USA)
Smart beds integrate with MEDI+SIGN ANTI-FALL™ technology to alert healthcare staff, patients and families of potential fall risks by sending alerts to the digital whiteboards in the patient’s room, in the hallway and at the nurses’ station. Alerts can range from bed height and bed rail position, to break checks and alarm reminders, and are determined based on the ...
Manufactured by:Masimo Corp based inIrvine, CALIFORNIA (USA)
Masimo SafetyNet-OPEN is a complete, easy-to-implement solution to help you safely bring people back into the workplace and keep them ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Empower is a genetic test for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis. Empower screens for genes associated with increased risk for common hereditary cancers. Our Empower multi-cancer panels include commonly screened-for genes associated with 12+ types of ...
by:Dominion Diagnostics based inNorth Kingstown, RHODE ISLAND (USA)
Dominion Diagnostics empowers pain practitioners to help the healthcare community in reducing the national epidemic of prescription drug abuse. Prescription monitoring plays an essential role in safely and effectively managing chronic pain, and provides evidence of compliance with the latest Industry guidelines and recommendations. ...
Manufactured by:Reichert, Inc based inDepew, NEW YORK (USA)
Ocular Response Analyzer® (ORA) G3 is the only device that measures Corneal Hysteresis (CH) and Corneal Compensated IOP (IOPcc). Corneal Hysteresis has consistently shown to be a more powerful predictor of, and strongly associated with, glaucoma progression, more so than key risk factors such as IOP and CCT. IOPcc is a pressure measurement that is less affected by corneal properties and more ...
Manufactured by:Haemonetics Corporation based inBoston, MASSACHUSETTS (USA)
Literature and ongoing trials have shown by adding the TEG® Hemostasis Analyzer System to your clinical practice and blood management program, you can help predict and manage coagulopathy (3-8), help assess the risk for re-operation (9-10), and realize cost savings through the reduction of unnecessary blood component transfusions (10-11). ...
Manufactured by:DxTerity Diagnostics Inc. based inRancho Dominguez, CALIFORNIA (USA)
The DxTerity Immunity Assessment Test measures COVID-19 neutralizing antibody levels from a small sample of blood. Knowing your neutralizing antibody levels can help you assess your risk of future symptomatic ...
by:Dominion Diagnostics based inNorth Kingstown, RHODE ISLAND (USA)
Prescription drug abuse has reached epidemic levels. Take a proactive approach to combat prescription drug abuse through medication monitoring and patient education. Dominion Diagnostics is ready to help you design a monitoring program for patients prescribed opioids, benzodiazepines, and other medications for chronic pain and other conditions. ...
by:ni2o, Inc. based inProvidence, RHODE ISLAND (USA)
Countering Communicable Diseases with our Five-Minute Test. Worldwide Testing Challenges: COVID-19 has opened our eyes to the many communities who don’t have adequate disease detection technology. Ni2o’s RapidTest instrument will allow for a variety of diseases to be detected from samples collected via a non-invasive method, removing the need for specialized testing equipment and ...